Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ADMT OTCMKTS:ENDVD NASDAQ:NDRA OTCMKTS:USAQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADMTADM Tronics Unlimited$0.08$0.08$0.05▼$0.12$5.64M0.161,145 shsN/AENDVDEndonovo Therapeutics$0.00$1.10▼$37.90$1.52M1.9811,850 shsN/ANDRAENDRA Life Sciences$4.90-0.9%$4.35$2.90▼$11.96$6.13M-0.1120,666 shs10,959 shsUSAQQHSLab$0.59$0.64$0.08▼$1.14$6.66M0.482,682 shs4,400 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADMTADM Tronics Unlimited0.00%+0.12%-7.33%+27.52%+19.66%ENDVDEndonovo Therapeutics0.00%0.00%0.00%0.00%-46.00%NDRAENDRA Life Sciences0.00%+3.07%+5.93%+35.00%-19.09%USAQQHSLab0.00%-6.06%-8.15%-24.39%+233.33%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADMTADM Tronics Unlimited$0.08$0.08$0.05▼$0.12$5.64M0.161,145 shsN/AENDVDEndonovo Therapeutics$0.00$1.10▼$37.90$1.52M1.9811,850 shsN/ANDRAENDRA Life Sciences$4.90-0.9%$4.35$2.90▼$11.96$6.13M-0.1120,666 shs10,959 shsUSAQQHSLab$0.59$0.64$0.08▼$1.14$6.66M0.482,682 shs4,400 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADMTADM Tronics Unlimited0.00%+0.12%-7.33%+27.52%+19.66%ENDVDEndonovo Therapeutics0.00%0.00%0.00%0.00%-46.00%NDRAENDRA Life Sciences0.00%+3.07%+5.93%+35.00%-19.09%USAQQHSLab0.00%-6.06%-8.15%-24.39%+233.33%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADMTADM Tronics Unlimited 0.00N/AN/AN/AENDVDEndonovo Therapeutics 0.00N/AN/AN/ANDRAENDRA Life Sciences 2.00Hold$30.00512.87% UpsideUSAQQHSLab 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ENDVD, NDRA, USAQ, and ADMT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/20/2026NDRAENDRA Life Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADMTADM Tronics Unlimited$3.20M1.76N/AN/A$0.01 per share8.34ENDVDEndonovo Therapeutics$170K0.00N/AN/A($0.59) per share0.00NDRAENDRA Life SciencesN/AN/AN/AN/A$1.92 per shareN/AUSAQQHSLab$2.69M2.47N/AN/A$0.14 per share4.21Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADMTADM Tronics Unlimited-$120KN/AN/AN/AN/A-0.20%-0.85%-0.32%N/AENDVDEndonovo Therapeutics-$400K-$10.00N/AN/AN/A-6,075.54%N/A-279.35%N/ANDRAENDRA Life Sciences-$7.03M-$8.92N/AN/AN/AN/A-397.71%-190.73%5/21/2026 (Estimated)USAQQHSLab$460K$0.0229.51N/AN/A16.98%N/A-5.88%5/18/2026 (Estimated)Latest ENDVD, NDRA, USAQ, and ADMT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2026Q1 2026NDRAENDRA Life Sciences-$1.23N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthADMTADM Tronics UnlimitedN/AN/AN/AN/AN/AENDVDEndonovo TherapeuticsN/AN/AN/AN/AN/ANDRAENDRA Life SciencesN/AN/AN/AN/AN/AUSAQQHSLabN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADMTADM Tronics UnlimitedN/A1.140.81ENDVDEndonovo TherapeuticsN/AN/AN/ANDRAENDRA Life SciencesN/A1.291.29USAQQHSLab0.061.961.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADMTADM Tronics UnlimitedN/AENDVDEndonovo TherapeuticsN/ANDRAENDRA Life Sciences1.19%USAQQHSLabN/AInsider OwnershipCompanyInsider OwnershipADMTADM Tronics Unlimited73.00%ENDVDEndonovo Therapeutics5.61%NDRAENDRA Life Sciences10.00%USAQQHSLab74.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADMTADM Tronics Unlimited2367.59 million18.25 millionNot OptionableENDVDEndonovo Therapeutics147,0001.23 millionN/ANot OptionableNDRAENDRA Life Sciences201.24 million1.12 millionNot OptionableUSAQQHSLab511.28 million2.91 millionNot OptionableENDVD, NDRA, USAQ, and ADMT HeadlinesRecent News About These CompaniesQHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support AssessmentApril 21, 2026 | globenewswire.comQHSLab Inc.April 1, 2026 | barrons.comQHSLab (OTCQB:USAQ) Reports Strong Fiscal 2025 Results with Revenue Growth, Expanding Margins, and Significant Balance Sheet ImprovementMarch 31, 2026 | globenewswire.comQhslab's Strategic Pivot: Harnessing AI Diagnostics for GrowthMarch 7, 2026 | aktiencheck.deAQHSLab, Inc.: QHSLab (OTCQB:USAQ) Reports Preliminary Unaudited 2025 Financial Results With Strong Revenue Growth, Expanding Margins, and Significant Debt ReductionJanuary 26, 2026 | finanznachrichten.deQHSLab (OTCQB:USAQ) Reports Preliminary Unaudited 2025 Financial Results With Strong Revenue Growth, Expanding Margins, and Significant Debt ReductionJanuary 26, 2026 | globenewswire.comQHSLab Simplifies Capital Structure With Debt-for-Equity DealJanuary 23, 2026 | tipranks.comQHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of GrowthJanuary 16, 2026 | globenewswire.comQHSLab, Inc.: QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor SessionJanuary 7, 2026 | finanznachrichten.deQHSLab reports strong 2025 growth and deleveraged balance sheetJanuary 6, 2026 | msn.comQHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor SessionJanuary 6, 2026 | globenewswire.comQHSLab Modifies Debt and Converts Note to EquityJanuary 2, 2026 | tipranks.comQHSLab strengthens balance sheet with new equity financingDecember 29, 2025 | msn.comQHSLab, Inc. (OTCQB:USAQ) Completes $500K Private Placement, Enters 2026 With Clean Capital StructureDecember 29, 2025 | globenewswire.comQHSLab (OTCQB:USAQ) Announces Launch of Q-Cog™ to Support Early Detection of Mild Cognitive Impairment and DementiaDecember 3, 2025 | globenewswire.comQHSLab Releases December 2025 Corporate PresentationDecember 1, 2025 | tipranks.comOther news to note for Nov. 20, 2025November 21, 2025 | bioworld.comBQHSLab Retires Convertible Debt, Strengthens Financial PositionNovember 18, 2025 | tipranks.comQHSLab (OTCQB:USAQ) Completes Repurchase of Legacy Debt, Enhancing Capital Structure, Strengthening Balance Sheet and Reducing Future DilutionNovember 18, 2025 | globenewswire.comQHSLab (OTCQB: USAQ) Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental HealthSeptember 2, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeENDVD, NDRA, USAQ, and ADMT Company DescriptionsADM Tronics Unlimited OTCMKTS:ADMT$0.08 0.00 (0.00%) As of 05/1/2026ADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. In addition, the company provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. Further, it offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Additionally, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.Endonovo Therapeutics OTCMKTS:ENDVDEndonovo Therapeutics, Inc. is a biotechnology company, which engages in the development of bio-electronic approach to regenerative medicine. The firm also develops, manufactures and distributes evolutionary medical devices focused on the healing of wounds and reduction of pain, edema and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, SofPulse, Electroceutical Therapy, and Scientific Studies. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.ENDRA Life Sciences NASDAQ:NDRA$4.89 -0.05 (-0.91%) Closing price 03:59 PM EasternExtended Trading$4.68 -0.22 (-4.39%) As of 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.QHSLab OTCMKTS:USAQ$0.59 0.00 (0.00%) As of 05/4/2026 09:30 AM EasternQHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
